Grant

Glycopeptide compositions

Patent Number US-11628200-B2

Publication Year 2023

Granted Year: 2023

Application Year 2021

Priority Year 2014

Jurisdiction US

Status Active

Inventors

JASPRICA IVONA KESER SABINA PINDRIC KATARINA

Applicants

  1. Xellia (Denmark)

    2. [NORA names: Xellia; Private Research]

Abstract

Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.

Patent Family Records (67)

USE OF A COMPOSITION AND AN EXCIPIENT, PHARMACEUTICAL COMPOSITION, AND, METHODS OF STABILIZING AN ANTIBIOTIC AND MANUFACTURING A STABLE AQUEOUS PHARMACEUTICAL SOLUTION  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, PINDRIC KATARINA, KESER SABINA

2024, BR-112017009405-B1

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2023, US-20230158101-A1

Glycopeptide compositions

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2023, US-11628200-B2

Glycopeptide compositions  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2023, NZ-731955-A

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2023, KR-20230096142-A

GLYCOPEPTIDE COMPOSITIONS  

셀리아 파마슈티칼즈 에이피에스 ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)

2023, KR-102603756-B1

GLYCOPEPTIDE COMPOSITIONS IN SOLUTION  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2023, EP-4147710-A1

Glycopeptide Compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2022, US-20220354927-A1

Glycopeptide compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2022, US-11517609-B2

Glycopeptide composition  

Xellia (Denmark), Xellia Pharmaceuticals ApS ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)

2022, JP-7032488-B2

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2022, HR-P20210342-T8

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2022, CY-1124011-T1

Glycopeptide Compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2021, US-20210220433-A1

Glycopeptide compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2021, US-11000567-B2

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2021, SI-3542812-T1

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2021, RS-61418-B1

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark)

2021, PT-3542812-T

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2021, PL-3542812-T3

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2021, HU-E053347-T2

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2021, HR-P20210342-T1

Glycopeptide compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2021, ES-2852550-T3

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2021, EP-3834837-A1

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2021, EP-3542812-B1

GLYCOPEPTIME COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) PINDRIC KATARINA, JASPRICA IVONA, KESER SABINA

2021, DK-3542812-T3

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) KESER SABINA, PINDRIC KATARINA, JASPRICA IVONA

2021, CY-1122960-T1

Glycopeptide compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS Yvonne Aspritsa, Sabine Keser, Katharina Pindyck

2021, CN-107073072-B

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, US-20200069768-A1

Glycopeptide compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, US-10849956-B2

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, SI-3215173-T1

ANTIBIOTIC COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) PINDRIC KATARINA, JASPRICA IVONA, KESER SABINA

2020, SA-517381446-B1

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, RS-59851-B1

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark)

2020, PT-3215173-T

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, PL-3215173-T3

Glycopeptide composition  

Xellia (Denmark), Xellia Pharmaceuticals ApS ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)

2020, JP-6797795-B2

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS IVONA JASPRICA, Sabina KESER, KATARINA PINDRIC

2020, JP-2020183424-A

Glycopeptide compositions  

IVONA JASPRICA, KATARINA PINDRIC, Sabina KESER, XELLIA PHARMACEUTICALS APS, Xellia (Denmark) IVONA JASPRICA, Sabina KESER, KATARINA PINDRIC

2020, IL-252120-B

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, HU-E049857-T2

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, HR-P20200101-T1

Glycopeptide Compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, ES-2769849-T3

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, EP-3215173-B8

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, EP-3215173-B1

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2020, EA-035368-B1

GLYCOPEPTIME COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) PINDRIC KATARINA, JASPRICA IVONA, KESER SABINA

2020, DK-3215173-T3

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2019, US-20190160142-A1

Glycopeptide compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2019, US-10188697-B2

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2019, EP-3542812-A1

Glycopeptide compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2019, AU-2015341763-B2

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) KATARINA PINDRIC, Sabina KESER, IVONA JASPRICA

2018, ZA-201702767-B

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2018, US-20180133286-A1

Glycopeptide compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2018, US-10039804-B2

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2018, TN-2017000182-A1

GLYCOPEPTIDE COMPOSITIONS.  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) KATARINA PINDRIC, IVONA JASPRICA, Sabina KESER

2018, MX-2017005749-A

ANTIBIOTIC COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2018, CR-20170234-A

antibiotic compositions.  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) IVONA JASPRICA, KATARINA PINDRIC, Sabina KESER

2018, BR-112017009405-A2

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS, Zellia Pharmaceuticals Aps JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2017, US-20170348385-A1

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2017, SG-11201703568W-A

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2017, PH-12017500720-A1

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2017, KR-20170078830-A

Glycopeptide composition  

Xellia (Denmark), Xellia Pharmaceuticals ApS ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)

2017, JP-2017533218-A

Glycopeptide compositions  

IVONA JASPRICA, KATARINA PINDRIC, Sabina KESER, XELLIA PHARMACEUTICALS APS, Xellia (Denmark) IVONA JASPRICA, Sabina KESER, KATARINA PINDRIC

2017, IL-252120-A0

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2017, EP-3215173-A1

Antibiotic compositions  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2017, CO-2017005391-A2

Glycopeptide compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2017, CN-107073072-A

Antibiotic compositions  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2017, CL-2017001139-A1

Glycopeptide compositions  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2017, AU-2015341763-A1

GLYCOPEPTIDE COMPOSITIONS  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2016, WO-2016071495-A1

GLYCOPEPTIDE COMPOSITIONS  

Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA

2016, CA-2964524-A1

Data Provider: Digital Science

LINKS
-

SUBJECTS
+

PATENT CATEGORIES
+

METRICS
+